КОМПЛЕКСНЫЙ ПОДХОД К КОМБИНИРОВАННОМУ ЛЕЧЕНИЮ ДИАБЕТИЧЕСКОГО МАКУЛЯРНОГО ОТЕКА

N. R. Yangieva, A. O. Giyasova

Передовая Офтальмология · 2023-yil

Annotatsiya

Annotation. Relevance. Diabetic retinopathy (DR) is one of the late complications of DM. An important role in the pathogenesis of its appearance is played by endothelial growth factor. Purpose of the study. Evaluate the effectiveness of SMPLE and its combination with anti-­VEGF therapy in the treatment of diabetic macular edema (DME) against the background of non-proliferative diabetic retinopathy. Materials and methods. In total, the study included 42 patients (67 eyes) with DME who were randomized into 2 groups. Group I anti-­VEGF therapy in the 1+PRN mode (once + «as needed»). Group II combined treatment was carried out: SMPLE + anti-­VEGF therapy (once + «as needed»). Results and conclusion. In patients receiving combination therapy, the frequency of additional injections was significantly lower: 67.5% of patients did not need further administration of anti-­VEGF drug after the loading phase compared with 11.1% in the monoanti-­VEGF therapy group. SMPLE at a wavelength of 577 nm is safe for the structures of the chorioretinal complex, since it does not have a destructive effect on the cells of the retinal pigment epithelium.

Maqola ma’lumotlari
MualliflarN. R. Yangieva, A. O. Giyasova
JurnalПередовая Офтальмология
Nashr sanasi2023-11-28
Jild5
Son5
Betlar74-76
Tilru
DOI10.57231/j.ao.2023.5.5.013

Передовая Офтальмология jurnalidan boshqa maqolalar

Передовая Офтальмология — barcha maqolalar